SCHEMBL23830372

SCHEMBL23830372

CCOC(=O)c1ncnc(OCCOC)c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.45
TSHR P16473 3/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
KDM5B Q9UGL1 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36
BRD4 O60885 1/20 0.36
GPR119 Q8TDV5 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TLR9 Q9NR96 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830396 0.86 HSD17B10 (0.47) HSD17B10TSHRALDH1A1GAAMAPT
SCHEMBL23830291 0.84 HSD17B10 (0.56) HSD17B10TSHRALDH1A1RAB9AMAPT
SCHEMBL23830298 0.78 ACACB (0.47) HSD17B10GPR119HTR2C
SCHEMBL16395514 0.77 HSD17B10 (0.42) HSD17B10TSHRALDH1A1GAAMAPT
SCHEMBL2258738 0.74 CA12 (0.42) HSD17B10TSHRALDH1A1RAB9AMAPT
SCHEMBL2743308 0.73 NPC1 (0.46) HSD17B10TSHRALDH1A1GAARAB9A
SCHEMBL18703821 0.73 HSD17B10 (0.50) HSD17B10ALDH1A1RAB9AMAPTPOLB
SCHEMBL25467307 0.72 TSHR (0.47) TSHRRAB9ANPC1CYP1A2
SCHEMBL23830322 0.72 KDM4E (0.43) HSD17B10TSHRALDH1A1GAAMAPT
SCHEMBL23830406 0.71 TSHR (0.40) HSD17B10TSHRKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA CADILA HEALTHCARE LIMITED (IN) 2021-09-23 US disclosed
CN-112543757-A Condensed azaheteroaryl compounds having antibacterial activity against tubercle bacillus 卡迪拉保健有限公司 2021-03-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292333-A1 CONDENSED AZAHETEROARYL COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AGAINST TUBERCULOSIS BACTERIA DPEP1, SAT1, PEPD HSD17B10 1210/4885TSHR 2466/4885ALDH1A1 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.